Comprehensive information site on mesothelioma diagnosis, treatment, coping, asbestos disease and financial assistance.

Mesothelioma Comprehensive Cancer Center News

Mesothelioma Victims Center Says Why Settle For Second Best When We Give ... - PR Web (press release)

2012-01-24
PR Web (press release)Mesothelioma Victims Center Says Why Settle For Second Best When We Give ...PR Web (press release)The Mesothelioma Victims Center says, "Why settle for second, or third best, when you can call us, and get the best specific mesothelioma cancer treatment options, or the specific names, and contacts of the best mesothelioma attorneys, all at the same ...and more »

UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients - MarketWatch (press release)

2012-01-20
UH Case Medical Center Offers New Therapy for Gynecologic Cancer PatientsMarketWatch (press release)20, 2012 /PRNewswire via COMTEX/ -- Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, ...and more »

Mesothelioma Attorneys Update Website to Help Veterans Diagnosed with Asbestos ... - San Francisco Chronicle (press release)

2012-01-11
PR Web (press release)Mesothelioma Attorneys Update Website to Help Veterans Diagnosed with Asbestos ...San Francisco Chronicle (press release)The primary cause of mesothelioma, a rare and aggressive form of cancer that affects the lining of the internal organs, is exposure to asbestos. Clapper Patti Schweizer & Mason (CPSM) have a newly updated section of their website specifically for US ...The Mesothelioma Victims Center's Unsurpassed Mesothelioma Victim's Help ...PR Web (press release)all 5 news articles »

Sidley Austin LLP | Microsoft Word - SA_ PD_ Single Clinical Trial Approvals ... - Linex Legal (press release) (registration)

2012-01-27
Sidley Austin LLP | Microsoft Word - SA_ PD_ Single Clinical Trial Approvals ...Linex Legal (press release) (registration)Dr. Robert Temple, FDA Center for Drug Evaluation & Research Associate Director for Medical Policy, quoted in Better Phase II Could Allow for More Single-Trial Approvals, THE PINK SHEET, Jan. 21, 2002, at 23. For a new drug to be approved under section ...